Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 4 to 5 amino acid residues in defined sequence
Reexamination Certificate
2006-02-21
2006-02-21
Gupta, Anish (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
4 to 5 amino acid residues in defined sequence
C530S331000, C514S018700
Reexamination Certificate
active
07001984
ABSTRACT:
Compounds having the formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
REFERENCES:
patent: 4395400 (1983-07-01), Konig et al.
patent: 99/61476 (1999-02-01), None
patent: 01/38347 (2001-05-01), None
patent: 01/38397 (2001-05-01), None
Dermer, Gerald ‘Another Anniversary for the War on Cancer’ Bio/Technology, vol. 12, pp. 320, Mar. 1994.
Gura, Trisha, ‘Systems for Identifying New Drugs are Often Faulty’ Science, vol. 278, pp. 1041-1042, Nov. 1997.
Golden, Fredrick, ‘Of Mice and Men: Don't Blame the Rodendt's’ Time, p. 44, May 1998.
Veggeberg, Scott. ‘Fighting Cancer with Angiogenesis Inhibitors’ The Scientist, vol. 16, No. 11, May 2002, pp. 1-5. accessible via “http://www.the-scientist.com”.
Black, Harvey ‘Angiogenesis—Promoting and Blocking—Comes into Focus’ The Scientist, vol. 12, No. 9, Apr. 1998, pp. 1-4. Accessible via “http://www.the-scientist.com”.
File Caplus on STN. DN No. 89:197926. Coomans et al. ‘Pharmacological Study and Synthesis of Peptide Analogs and Homologs of Various Fragments of Cobramine F12’ Ingenieur Chimiste, vol. 59 (284-285), pp. 48-66, 1977. Abstract only, Abstract date 1978.
File Caplus on STN. DN No. 122:10696. Mitsufuji et al. JP 06220088. Aug. 9, 1994. Abstract only, ABstract date 1995.
File Caplus on STN. DN No. 83:202091. Auna et al. ‘Myotropic Effect of Common Fragment of Some Peptide Hormones,’ Latvijas PST Zinatnu Akademijas Vestis (1975), (7), pp. 104-109. Abstract only. Abstract entered in STN 12 May 1984.
File Caplus on STN. DN No. 120:164914. Matsumura et al. JP 05306295. Nov. 19, 1993. Abstract only. Abstract Date 1994.
Bradley Michael F.
Haviv Fortuna
Abbott Laboratories
Corbin Johanna M.
Gupta Anish
Steele Gregory W.
LandOfFree
Di-, tri-, and tetra-peptides having antiangiogenic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Di-, tri-, and tetra-peptides having antiangiogenic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Di-, tri-, and tetra-peptides having antiangiogenic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3697726